预测认知衰退:哪个更有用,基线粉样蛋白水平还是纵向变化?
Gengsheng Chen1, Nicole S McKay1, Brian A Gordon2
1Departments of Radiology, Washington University in St. Louis School of Medicine, St. Louis, MO, USA; Knight Alzheimer's Disease Research Center, Washington University in St. Louis School of Medicine, St. Louis, MO, USA.
NeuroImage. Clinical
|December 27, 2023
概括
一次检测β-粉样蛋白 (Aβ) 的正电子发射断层扫描 (PET) 扫描足以预测阿尔茨海默病 (AD) 的认知衰退. 一旦确定了粉样蛋白阳性,纵向的Aβ-PET测量不会提供额外的预测价值.
科学领域:
- 神经学 神经学
- 放射学 放射学是一门学科.
- 生物标志物 生物标志物
背景情况:
- 通过生物标志物的早期阿尔茨海默病 (AD) 检测对于治疗的发展至关重要.
- 定子发射断层扫描 (PET) 已建立用于检测大脑β-粉样蛋白 (Aβ) 斑块.
- 以前的研究表明,横截面生物标志物预测认知能力下降,但纵向Aβ-PET的价值仍然不清楚.
研究的目的:
- 评估11C-匹兹堡化合物B (PiB) Aβ-PET的基线或纵向变化是否预测阿尔茨海默病的认知衰退.
- 为了比较单个Aβ-PET扫描的预测能力与随着时间的推移跟踪Aβ积累率.
主要方法:
- 分析了153名参与者的数据,并进行了PiB-PET扫描和临床评估.
- 与认知综合分数变化相关的基线Aβ-PET水平.
- 研究了PiB-PET Aβ变化速率与认知衰退之间的关联.
- 研究了APOE ε4载体状态对预测的影响.
主要成果:
- 较高的基线Aβ水平显著预测了更快的认知衰退.
- 在Aβ-PET变化率和认知衰退之间没有发现显著的关联.
- APOE ε4载体状态影响了纵向Aβ-PET测量的预测能力.
结论:
- 一次基线Aβ-PET扫描足够预测阿尔茨海默病的认知衰退.
- 对Aβ积累的纵向监测对于预测粉样蛋白阳性个体的认知衰退没有额外的好处.
- 这些发现支持基线Aβ-PET足以用于AD的预后评估.
相关概念视频
Longitudinal Research
12.0K
Sometimes we want to see how people change over time, as in studies of human development and lifespan. When we test the same group of individuals repeatedly over an extended period of time, we are conducting longitudinal research. Longitudinal research is a research design in which data-gathering is administered repeatedly over an extended period of time. For example, we may survey a group of individuals about their dietary habits at age 20, retest them a decade later at age 30, and then again...
12.0K
Longitudinal Studies
165
Longitudinal studies are also widely used in other medical and social science fields. For instance, in cardiovascular research, they can monitor patients' health over decades to identify risk factors for heart disease, such as high cholesterol or smoking, and evaluate the long-term effectiveness of preventive measures. Similarly, in mental health studies, researchers might follow individuals from adolescence into adulthood to understand the development and progression of conditions like...
165
Alzheimer's Disease: Overview
491
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
491
Cognitive Development During Adulthood
114
Cognitive development continues throughout adulthood, undergoing significant shifts across early, middle, and late stages. Individual transition occurs from adolescent idealism to pragmatic and adaptable thinking in early adulthood. During this period, individuals learn to integrate personal beliefs with the recognition that other perspectives are equally valid. Exposure to the complexities of modern society, diverse experiences, and higher education contribute to this adaptive thought process,...
114


